127 related articles for article (PubMed ID: 2622013)
1. [Clinical significance of factor IX analysis in blood coagulation tests].
Kakishita E; Nishida Y
Nihon Rinsho; 1989 Dec; 48 Suppl():834-6. PubMed ID: 2622013
[No Abstract] [Full Text] [Related]
2. [Factor IX and factor IX inhibitor].
Higasa S
Nihon Rinsho; 2004 Dec; 62 Suppl 12():647-50. PubMed ID: 15658413
[No Abstract] [Full Text] [Related]
3. Immune reactive factor IX in acquired factor IX deficiency.
Lechner K
Thromb Diath Haemorrh; 1972 Feb; 27(1):19-24. PubMed ID: 5033668
[No Abstract] [Full Text] [Related]
4. [Presence of inactive factor ix in variants of hemophilia, type B, and in carriers of hemophilia B].
Elodi S
Minerva Med; 1975 Jun; 66(42):2037-43. PubMed ID: 1138213
[No Abstract] [Full Text] [Related]
5. Proceedings: Electroimmunoassay of human coagulation factor IX in the detection of variants of haemophilia B.
Orstavik K; Osterud B
Thromb Diath Haemorrh; 1975 Sep; 34(1):322-3. PubMed ID: 1188733
[No Abstract] [Full Text] [Related]
6. Evaluation of APTT reagent sensitivity to factor IX and factor IX assay performance. Results from the College of American Pathologists Survey Program.
Brandt JT; Arkin CF; Bovill EG; Rock WA; Triplett DA
Arch Pathol Lab Med; 1990 Feb; 114(2):135-41. PubMed ID: 2405809
[TBL] [Abstract][Full Text] [Related]
7. Detection and clinical significance of PIVKA.
Veltkamp JJ
Mayo Clin Proc; 1974 Dec; 49(12):923-4. PubMed ID: 4444340
[No Abstract] [Full Text] [Related]
8. Performances of an artificial reagent for the one-stage factor IX assay.
Meunier L; Allain JP; Frommel D
Thromb Diath Haemorrh; 1975 Jun; 33(3):547-52. PubMed ID: 1154311
[TBL] [Abstract][Full Text] [Related]
9. Factor IX Zutphen. A genetic variant of blood coagulation factor IX with an abnormally high molecular weight.
Bertina RM; Van Der Linden IK
J Lab Clin Med; 1982 Nov; 100(5):695-704. PubMed ID: 7130828
[TBL] [Abstract][Full Text] [Related]
10. Electroimmunoassay of factor IX in patients with liver damage and vitamin K unresponsive coagulation disorder.
Girolami A; Burul A; Cappellato G; Dal Bo Zanon R
Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(1):65-71. PubMed ID: 88391
[TBL] [Abstract][Full Text] [Related]
11. The comparison of CS-2500 and BCS XP coagulation analyzers for Factor VIII and Factor IX one-stage clotting assays.
Genc S; Aydin AF; Karaca E; Ömer B
Int J Lab Hematol; 2019 Oct; 41(5):e124-e127. PubMed ID: 31034727
[No Abstract] [Full Text] [Related]
12. Trypsin clotting time (K-test) in hemophilia A and in hemophilia B1.
Girolami A; Dal Bo Zanon R; Procidano M
Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(6):863-71. PubMed ID: 6176512
[TBL] [Abstract][Full Text] [Related]
13. A simple assay for human factor IX: use of canine hemophilia B plasma as substrate.
Goldsmith JC; Chung KS; Roberts HR
Thromb Res; 1978 Mar; 12(3):497-502. PubMed ID: 653637
[No Abstract] [Full Text] [Related]
14. [An unified method of one-stage quantitative analysis of factors VIII and IX. I. (Results of the studies of the working group of the All-Union Problem-Solving Commission on "Pathology of hemostasis")].
Barkagan ZS
Gematol Transfuziol; 1991 Apr; 36(4):33-5. PubMed ID: 1906034
[No Abstract] [Full Text] [Related]
15. [Thromboplastin generation test and possible errors in its reproducibility].
Tarasova LN
Lab Delo; 1980; (11):669-71. PubMed ID: 6160299
[No Abstract] [Full Text] [Related]
16. [Clinical significance of factor VIII analysis in blood coagulation tests].
Kakishita E; Nishida Y
Nihon Rinsho; 1989 Dec; 48 Suppl():831-3. PubMed ID: 2516159
[No Abstract] [Full Text] [Related]
17. [Blood coagulation disorders caused by abnormal blood coagulation factors].
Fiedler H
Z Arztl Fortbild (Jena); 1972 Jul; 66(13):692-8. PubMed ID: 4636972
[No Abstract] [Full Text] [Related]
18. [Clinical significance of factor VII analysis in blood coagulation tests].
Matsumoto K; Ikematsu S
Nihon Rinsho; 1989 Dec; 48 Suppl():828-30. PubMed ID: 2622012
[No Abstract] [Full Text] [Related]
19. Prosthetic heart valves and rare hypersensitivity to vitamin K antagonists resulting from factor IX mutation: how to manage anticoagulation?
Holbro A; Marbet GA; Tran TH; Oldenburg J; Friesewinkel O; Tsakiris DA
Haemophilia; 2010 Jan; 16(1):187-9. PubMed ID: 19804386
[No Abstract] [Full Text] [Related]
20. Coagulation factor IX in normal and haemophilia B plasma.
Somer JB; Castaldi PA
Br J Haematol; 1970 Feb; 18(2):147-59. PubMed ID: 5439522
[No Abstract] [Full Text] [Related]
[Next] [New Search]
